Outcomes after haploidentical cell transplantation with posttransplant cyclophosphamide: a systematic review and meta-analysis comparing myeloablative with reduced-intensity conditioning regimen and bone marrow with peripheral blood stem-cell graft: PTCy: PBSC or BM and MAC or RIC for Haplo-HCT with PTCy

Haploidentical hematopoietic cell transplantation (Haplo-HCT) with posttransplant cyclophosphamide (PTCy) is emerging as a new standard in the western world for Haplo-HCT. The procedure is relatively straightforward and easily reproducible1, obviating the need for expensive T-cell depletion techniques and greatly expanding the pool of donors.

Source: Biology of Blood and Marrow Transplantation - June 16, 2021 Category: Hematology Authors: Leonardo Javier Arcuri, Nelson Hamerschlak, Vanderson Rocha, Carmem Bonfim, Mariana Nassif Kerbauy Source Type: research